1. MARKETS
  2. SECTOR : HEALTHCARE
  3. INDUSTRY : HEALTHCARE FACILITIES
  4. HEALTHCARE GLOBAL ENTERPRISES LTD.
Healthcare Global Enterprises Ltd.
NSE: HCG | BSE: 539787

Healthcare Global Live Share Price Today, Share Analysis and Chart

Mid-range Performer
aboutHealthcare Global Enterprises Ltd. (HCG) is a specialized healthcare provider in India, primarily focused on oncology and fertility services. The company operates the largest oncology-focused hospital network in the country, utilizing a "Focused Fact... Read More
Occupancy RateARPOB (Rev per Bed)
Ask AI about Healthcare Global
585.55-5.90(-1.00%)
133.8K
NSE+BSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting
The next board meeting for Healthcare Global is on 05 Nov 2026 for the purpose of Quarterly Results See details
Loading...
- / 100
- / 100
51.2 / 100
Mid-range PerformerThese stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investorsView SimilarEmbed DVM
Analyst Price Target
-

12

S

13

W

7

O

0

T

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

Medium rank

11Positive12Negative

47.8%Pass in checklist

045
55
100

PE Valuation Check

Right Now
Overvalued
-43.8%
1 Year Forward
Undervalued
235.3%
INSIGHTHealthcare Global is overvalued at current PE, but undervalued on future earnings estimates

Healthcare Global Stock Price Analysis

Day Price Range

-1.0% 1 Day return
585.6 (LTP)
580.2594
LowHigh

Week Price Range

6.5% 1 Week return
585.6 (LTP)
543.7598.6
LowHigh

Month Price Range

-16.8% 1 Month return
585.6 (LTP)
538.6710
LowHigh

52 Week Price Range

-23.2% 1 Year return
585.6 (LTP)
513.3775
LowHigh
View full Price History/Seasonality

Healthcare Global Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Miss

Healthcare Global's Revenue was lower than average estimate 3 times in past 3 years

EPS forecast

CURRENT EPS
1
AVG. ESTIMATE
8.6
LOW ESTIMATE
5.5
HIGH ESTIMATE
10.6
CURRENT EPS
AVG. ESTIMATE
Hit

EPS is expected to grow by 793.8% in FY27

Consensus Recommendation

9 ANALYST Recommendations
STRONG BUY

The consensus recommendation from 9 analysts for Healthcare Global is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get
Upgrade Now

Healthcare Global Technical Analysis

Healthcare Global EMA & SMA

Bearish-4
2 bullish, 6 bearish
Bullish2
Bearish6
5 Day582.9
10 Day583.5
12 Day586.3
20 Day601.0
26 Day611.6
50 Day636.6
100 Day646.2
200 Day639.1

Healthcare Global Delivery And Volume

Daily Avg. Delivery Volume %
30 Oct, 202683.0%
Week69.1%
Month61.7%

Healthcare Global Active Candlesticks

Hikkake Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Healthcare Global Resistance and Support

586.57
Pivot
First Resistance593.0
Second Resistance600.4
Third Resistance606.8
First Support579.1
Second Support572.7
Third Support565.3
Day RSI40.2
Day MACD-25.3
Day MFI29.8
Day MACD Signal Line-29

Healthcare Global Beta

1 Month0.5
1 Year0.7
3 Month0.3
3 Year0.6

Healthcare Global Price Change Analysis

↓-16.8%
Over 1 Month
LowHigh
538.7710
↓-12.6%
Over 3 Months
LowHigh
538.7775
↑2.7%
Over 6 Months
LowHigh
538.7775
↓-23.2%
Over 1 Year
LowHigh
513.3775
All Technicals →

Healthcare Global Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Hector Asia Holdings Ii Pte. Ltd.Promoter81,027,08754.3 %
Nippon Life India Trustee Ltd-A/C Nippon India ElsDii8,780,0235.9 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Healthcare Global Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
ACESO COMPANY PTE LTD.BlockSell10 Sep 20256956,300,000NSE
NIPPON INDIA MUTUAL FUNDBlockPurchase10 Sep 20256954,400,000NSE
MORGAN STANLEY ASIA SINGAPORE PTEBlockPurchase10 Sep 2025695880,000NSE
PLUTUS WEALTH MANAGEMENT LLPBlockPurchase10 Sep 2025695720,000NSE
MOTILAL OSWAL MUTUAL FUNDBlockPurchase10 Sep 2025695300,000NSE
ACESO COMPANY PTE LTD.BulkSell10 Sep 20256956,300,000NSE
ACESO COMPANY PTE LTD.BulkSell10 Sep 2025695.011,641,913NSE
AXIS MUTUAL FUNDBulkPurchase10 Sep 2025695952,700NSE
MORGAN STANLEY ASIA SINGAPORE PTEBulkPurchase10 Sep 2025695880,000NSE
NIPPON INDIA MUTUAL FUNDBulkPurchase10 Sep 20256954,400,000NSE
All deals
All insider trades

Healthcare Global Corporate Actions

Healthcare Global Board Meetings

Healthcare Global past and upcoming board meetings.

#Ex-Date
PurposeNotes
105 Nov 2026
Quarterly Results-
206 Aug 2026
Quarterly Results-
319 May 2026
Audited Results-
417 Feb 2026
Rights issue of Equity Shares-
505 Feb 2026
Quarterly Results-

Healthcare Global Rights issue

Healthcare Global rights issue history, along with record, ex-rights dates, and rights ratios.

#Ex-Date
RatioFace ValuePremiumRecord Date
102 Mar 2026
1.0:17.01050202 Mar 2026
All Corporate Actions

Healthcare Global Research Reports

Healthcare Global research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
130 Sep 2026Prabhudas Lilladhar820668.75Buy22.62%-12.44%pdf
208 Aug 2026ICICI Securities Limited800675.85Buy18.37%-13.36%pdf
320 May 2026ICICI Direct780627Buy24.4%-6.61%pdf
426 Feb 2026ICICI Direct
Target
710575.65Buy23.34%1.72%pdf
518 Feb 2026Geojit BNP Paribas
Reco
724594.85Buy21.71%-1.56%pdf
All Reports of Healthcare

Healthcare Global Corporate Filings

Healthcare Global BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
29 Oct 2026
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement in respect of Special Window for transfer and dematerialisation of Physical Securities of the Company.
PDF
15 Oct 2026
HealthCare Global Enterprises Ltd - 539787 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, of the Company for the quarter ended September 30, 2026.
PDF
13 Oct 2026
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Further to our intimation made on October 13, 2026, regarding the meeting of the Board of Directors of the Company scheduled to be held on Thursday, November 05, 2026, inter alia, to consider, approve and take on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and six months ended September 30, 2026 ('Unaudited Financial Results'), we wish to inform you that an Earnings Conference Call has been scheduled for Friday, November 06, 2026, at 12:30 p.m. (IST), to discuss the Unaudited Financial Results of the Company.
PDF
13 Oct 2026
HealthCare Global Enterprises Ltd - 539787 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Both Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30, 2026.
Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve inter-alia the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026
PDF
05 Oct 2026
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Acquisition
Pursuant to Regulation 30 of SEBI Listing Regulations, we would like to inform you that Healthcare Global (Kenya) Private Limited, a step-down subsidiary of the Company has today, i.e., October 05, 2026, entered into a Share Purchase Agreement with Meditec Systems Limited for acquisition of 10 (ten) ordinary shares of Advanced Molecular Imaging Limited held by Meditec, for an aggregate consideration of 42,150 Kenyan Shillings (approximately INR 31,288 as on October 05, 2026).
PDF
VIEW ALL

Healthcare Global DocumentsAsk MarketMind AI

Healthcare Global Earnings Call

Healthcare Global earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
10 Aug 2026HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptLink
07 Aug 2026HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeLink
07 Aug 2026Healthcare Global Enterprises Results Earnings Call for Q1FY27AudioVideo
20 May 2026Healthcare Global Enterprises Results Earnings Call for Q4FY26 & Full YearAudioVideo
13 Feb 2026HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptLink
view all

Healthcare Global Annual Reports

Healthcare Global financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026Link
2025Annual Report Mar-2025Link
2024Annual Report Mar-2024Link
2023Annual Report Mar-2023Link
2022Annual Report Mar-2022Link

Healthcare Global Credit Ratings

Healthcare Global credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
11 Jun 2026icra ratingsHCG Manavata Oncology LLPChange in LimitsLink
24 Mar 2026icra ratingsHCG Manavata Oncology LLPRatings Reaffirmed and Assigned for enhanced amountLink
24 Mar 2026icra ratingsHCG Kolkata Cancer Care LLPRatings ReaffirmedLink
24 Mar 2026icra ratingsHCG NCHRI Oncology LLPRatings Reaffirmed and Assigned for enhanced amountLink
24 Mar 2026icra ratingsHCG Rajkot Hospitals LLPRatings ReaffirmedLink

Healthcare Global Investor Presentations

Healthcare Global investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
06 Aug 2026HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
19 May 2026HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
06 Feb 2026HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
05 Feb 2026HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
04 Dec 2025HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Investor PresentationLink

Healthcare Global - Company Profile

Healthcare Global Management Structure

Healthcare Global management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
MANISH MATTOOExecutive Director,Chief Executive Officer304.4Mar 26
Anjali Ajaikumar RossiExecutive Director150Mar 26
Dr. Bharat S. GadhaviRegional Director137.7Mar 26
Dr. Rupali BasuSenior Vice President,Regional Business Head130Mar 26
George Philip AlexRegional Business Head109Mar 26
Manisha KumarRegional Business Head92.5Mar 26
Mr. Madan Kumar SampathChief Supply Chain Officer71.5Mar 26
SUNU MANUELCompany Secretary,Compliance Officer56.2Mar 26
Mr. Manu Sankar DasChief Marketing Officer-Mar 26
Mr. Ravi GothwalAssistant Vice President(Investor Relations)-Mar 26
Mr. Pankaj GautamChief Information Officer-Mar 26
Dr. Naveen R NagarHead(Clinical Strategy)-Mar 26
Ms. Deepti Gautam TewariChief Human Resources Officer(Human Resources)-Mar 26
Mr. Vijaykumar Shanbhag SChief Internal Auditor,Chief Risk Officer-Mar 26
Mr. Gopi LamaHead(Domestic Sales)-Mar 26
Mr. Sanjeev KumarChief Financial Officer-Mar 26

Healthcare Global Board of Directors

Healthcare Global Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
BASAVALINGA AJAIKUMAR SADASHIVAIAHChairman (Non-Executive)600Mar 25
Anjali Ajaikumar RossiNon-Exec & Non-Independent Dir150Mar 25
SUNU MANUELCompany Sec. & Compli. Officer56Mar 25
Geet MathurIndependent Non Exe. Director20Mar 25
RAJAGOPALAN RAGHAVANIndependent Non Exe. Director20Mar 25
Pradip M. KanakiaIndependent Non Exe. Director20Mar 25
Rajiv MaliwalIndependent Non Exe. Director20Mar 25
MANISH MATTOOExecutive Director & CEO-Mar 25
AKSHAY TANNANon-Exec & Non-Independent Dir-Mar 25
SIMRUN MEHTANon-Exec & Non-Independent Dir-Mar 25
Bijou KurienIndependent Non Exe. Director-Mar 25
Website: www.hcgel.com

About the company - Business Profile

Healthcare Global Enterprises Ltd. (HCG) is a specialized healthcare provider in India, primarily focused on oncology and fertility services. The company operates the largest oncology-focused hospital network in the country, utilizing a "Focused Factory" model to provide comprehensive cancer care including diagnostics, radiation, medical, and surgical oncology.

Key Points

  • Key Facts: Headquartered in Bengaluru, HCG was founded to address the growing demand for specialized cancer care. It is listed on both the NSE and BSE. As of 2025, KKR is a majority shareholder and promoter.
  • Operations and Resources:
    • Network: Operates 25 hospitals and 6 multispecialty hospitals.
    • Infrastructure: Total bed capacity of 1,493 (expanding to 2,500+ across the platform).
    • Equipment: Features 41 Linear Accelerators (LINACs), 19 PET CT scanners, and 8 robotic surgical systems.
    • Talent: Employs 6,736 personnel, including 2,376 nurses, 114 resident doctors, and 3,388 visiting doctors.
  • Market Significance: HCG holds top 3 market positions in 16 of the 19 cities where it operates (excluding Chennai). It focuses on a personalized, patient-centric approach supported by a multidisciplinary "Tumor Board."
  • Business Model: The company follows a vertically integrated "one-stop solution" approach for oncology. Its core strength lies in its high-end clinical outcomes, evidenced by an industry-leading mortality rate of 0.9%.
  • Revenue Breakdown (FY2024-25):
    • Total Revenue from Operations: ₹22,228 million.
    • EBITDA: ₹3,868 million (Adjusted EBITDA Margin: 17.4%).
    • Segmental Performance: Oncology remains the primary driver. The international center in Kenya contributed ₹430 million in FY2025. The fertility business, Milann, reported ₹1,570 million in revenue for 9MFY26.
  • Technology and Innovation:
    • Advanced Diagnostics: Operates Triesta Sciences, a network of CAP and NABL accredited oncology diagnostic labs providing genomics and molecular diagnostics.
    • Therapeutics: Implementation of Actinium and Lutetium therapies, bone marrow transplants, and immunotherapy.
    • Robotics: Conducted 1,077 robotic surgeries in FY2025.
  • Strategic Initiatives:
    • Expansion: Ongoing CAPEX of ₹1,290 million for a North Bangalore facility (expected Q4FY26) and ₹290 million for the Whitefield COE extension (expected FY27).
    • Divestment/Restructuring: The company is evaluating strategic options for its fertility business, Milann, to sharpen its focus exclusively on cancer care.
    • Efficiency: Transitioned from a consolidation phase (FY20-FY25) toward a growth phase, achieving a revenue CAGR of 15% and EBITDA CAGR of 18% over the last five years.

References

  1. Annual Report May 2025
  2. Investor Presentation Feb 2026
  3. Earnings Call Dec 2025
  4. Annual Report May 2024

Healthcare Global FAQ

Healthcare Global today is trading in the red, down by 1% at ₹585.55.
Healthcare Global is currently trading down 1% on an intraday basis. In the past week the stock rose 6.53%. Stock has been down 12.56% in the past quarter and fell 23.2% in the past year. You can view this in the share price history/seasonality section.
Healthcare Global is listed on NSE with the ticker HCG and on BSE as 539787. It's currently trading on NSE at a share price of ₹585.55 and on BSE with a share price of ₹585.
The market cap of Healthcare Global is ₹8,742.39 Cr. as of Oct 30, 2026.
Healthcare Global has never announced any dividend since the time of its listing on the BSE/NSE exchanges.
Healthcare Global has never issued stock splits or bonus shares since the time of its listing on the BSE/NSE exchanges.
Healthcare Global reported ₹707.23 Cr. in revenue, ₹13.77 Cr. in net profit, and ₹134.39 Cr. in EBITD as of Aug 06, 2026 for Q1 FY26-27.
According to the predictions of 9 analysts, the share price prediction for Healthcare Global is ₹816 with an upside of 39%.
The PE ratio of Healthcare Global is 383.44 as of Oct 30, 2026.
The PB ratio of Healthcare Global is 6.49 as of Oct 30, 2026.
You can view the latest analyst reports on the Healthcare Global reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.
Ask AI
×